Dr. Jamie Sturgill’s research focuses on helping her fellow Kentuckians battle lung disease. Learn how NIH funding supports core research facilities making this work possible.
With NIH support, Vince Venditto identified a cardiovascular biomarker that helps predicts risk of heart attack or stroke. He seeks to harness the immune system for treatment and prevention.
The College of Pharmacy will host its 11th annual Therapeutics, Outcomes, Discovery & Delivery (TODD) Symposium from 8 a.m.–5 p.m. April 12, at the Lee T. Todd, Jr. Building.
While previous research has shown that the COVID-19 vaccine is safe for pregnant women, a new study by UK researchers finds that maternal vaccinations are an effective way to protect both mom AND baby until the baby becomes eligible for the vaccine.
Ilhem Messaoudi, Ph.D., chair of the Department of Microbiology, Immunology and Molecular Genetics in the UK College of Medicine, shares ways to stay healthy during the holiday season.
Ilhem Messaoudi, Ph.D., and Jamie Sturgill, Ph.D., are combining their areas of expertise to better understand how heavy alcohol use affects a specific group of immune cells and their function in the lungs.
Findings from a new University of Kentucky College of Medicine study published in the Journal of Biological Chemistry may lead to a new treatment against Toxoplasma gondii, the parasite that causes toxoplasmosis.
University of Kentucky immunology and virology expert Ilhem Messaoudi, Ph.D., answers questions about the monkeypox virus — including symptoms, risk, and treatment.
According to a new University of Kentucky College of Medicine study, asymptomatic COVID-19 infection during pregnancy could still have potential long-term consequences for a developing baby.
UK College of Medicine researcher Ilhem Messaoudi, Ph.D., has dedicated her career to developing a better understanding of how the immune system works, paving the way for improving how people respond to vaccines and infections.
